Literature DB >> 15640155

Systematic evaluation of anti-apoptotic growth factor signaling in vascular smooth muscle cells. Only phosphatidylinositol 3'-kinase is important.

Marius Vantler1, Evren Caglayan, Wolfram H Zimmermann, Anselm T Bäumer, Stephan Rosenkranz.   

Abstract

Peptide growth factors contribute to the pathogenesis of cardiovascular diseases by inducing a variety of cellular responses including anti-apoptotic effects. Several of the signaling molecules that are activated by growth factor receptors such as Src family kinases (Src), phosphatidylinositol 3'-kinase (PI3K), phospholipase Cgamma (PLCgamma), Ras, and SHP-2 were shown to mediate survival signals. We systematically investigated the relative contribution of each signaling molecule for growth factor-dependent cell survival in vascular smooth muscle cells (VSMC). Our approach was the use of mutated plateletderived growth factor (PDGF) beta-receptors (betaPDGFR) in which the tyrosine residues required for binding of each signaling molecule were individually mutated to phenylalanine. To bypass endogenous PDGFR in VSMC we used chimeric receptors (ChiRs), containing the extracellular domain of the macrophage colony-stimulating factor (M-CSF) receptor and the cytoplasmic domain of the wild type (WT) or mutated betaPDGFR. Selective activation of the ChiR-WT with M-CSF significantly reduced apoptosis to the same extent as PDGF-BB in non-transfected cells. Deletion of the binding site for PI3K, but not for Src, RasGAP, SHP-2, or PLCgamma, completely abolished the anti-apoptotic effect. Consistently, a ChiR mutant that only binds PI3K was fully able to mediate cell survival as efficiently as the ChiR-WT. Furthermore, the PDGF-dependent anti-apoptotic effect in non-transfected cells was completely abolished by the PI3K inhibitor wortmannin, whereas inhibitors of Src, PLCgamma, ERK, or p38 MAP kinase had no effect. The exploration of downstream signaling events revealed that PDGF-BB activates the anti-apoptotic Akt signaling pathway in a PI3K-dependent manner. Moreover, Akt phosphorylates and thus inactivates the pro-apoptotic proteins BAD and Forkhead transcription factors (FKHR, FKHRL1). We conclude that growth factor-dependent cell survival in VSMC is mediated only by activation of the PI3K/Akt pathway, whereas all other receptor-associated signaling molecules do not play a significant role.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15640155     DOI: 10.1074/jbc.M413310200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  The survival kinases Akt and Pim as potential pharmacological targets.

Authors:  Ravi Amaravadi; Craig B Thompson
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

Review 2.  [Growth factors].

Authors:  N Hunzelmann; S Eming; S Rosenkranz
Journal:  Z Rheumatol       Date:  2007-07       Impact factor: 1.372

3.  Reversal of experimental pulmonary hypertension by PDGF inhibition.

Authors:  Ralph Theo Schermuly; Eva Dony; Hossein Ardeschir Ghofrani; Soni Pullamsetti; Rajkumar Savai; Markus Roth; Akylbek Sydykov; Ying Ju Lai; Norbert Weissmann; Werner Seeger; Friedrich Grimminger
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

4.  Disruption of platelet-derived growth factor-dependent phosphatidylinositol 3-kinase and phospholipase Cγ 1 activity abolishes vascular smooth muscle cell proliferation and migration and attenuates neointima formation in vivo.

Authors:  Evren Caglayan; Marius Vantler; Olli Leppänen; Felix Gerhardt; Lenard Mustafov; Henrik Ten Freyhaus; Kai Kappert; Margarete Odenthal; Wolfram H Zimmermann; Michelle D Tallquist; Stephan Rosenkranz
Journal:  J Am Coll Cardiol       Date:  2011-06-21       Impact factor: 24.094

5.  Genetic Ablation of PDGF-Dependent Signaling Pathways Abolishes Vascular Remodeling and Experimental Pulmonary Hypertension.

Authors:  Henrik Ten Freyhaus; Eva M Berghausen; Wiebke Janssen; Maike Leuchs; Mario Zierden; Kirsten Murmann; Anna Klinke; Marius Vantler; Evren Caglayan; Tilmann Kramer; Stephan Baldus; Ralph T Schermuly; Michelle D Tallquist; Stephan Rosenkranz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03-05       Impact factor: 8.311

6.  An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension.

Authors:  Georg Hansmann; Vinicio A de Jesus Perez; Tero-Pekka Alastalo; Cristina M Alvira; Christophe Guignabert; Janine M Bekker; Stefan Schellong; Takashi Urashima; Lingli Wang; Nicholas W Morrell; Marlene Rabinovitch
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

7.  Sodium tanshinone IIA sulfonate inhibits hypoxia-induced enhancement of SOCE in pulmonary arterial smooth muscle cells via the PKG-PPAR-γ signaling axis.

Authors:  Qian Jiang; Wenju Lu; Kai Yang; Cyrus Hadadi; Xin Fu; Yuqin Chen; Xin Yun; Jie Zhang; Meichan Li; Lei Xu; Haiyang Tang; Jason X-J Yuan; Jian Wang; Dejun Sun
Journal:  Am J Physiol Cell Physiol       Date:  2016-05-18       Impact factor: 4.249

8.  Sildenafil inhibits hypoxia-induced transient receptor potential canonical protein expression in pulmonary arterial smooth muscle via cGMP-PKG-PPARγ axis.

Authors:  Jian Wang; Kai Yang; Lei Xu; Yi Zhang; Ning Lai; Hua Jiang; Yajie Zhang; Nanshan Zhong; Pixin Ran; Wenju Lu
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

9.  Platelet-derived growth factor-C (PDGF-C) induces anti-apoptotic effects on macrophages through Akt and Bad phosphorylation.

Authors:  Dain Son; Yi Rang Na; Eung-Soo Hwang; Seung Hyeok Seok
Journal:  J Biol Chem       Date:  2014-01-13       Impact factor: 5.157

10.  Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling.

Authors:  Gemma E White; Thomas C C Tan; Alison E John; Carl Whatling; William L McPheat; David R Greaves
Journal:  Cardiovasc Res       Date:  2009-10-19       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.